Coagulation Factor XI Promotes Distal Platelet Activation and Single Platelet Consumption in the Bloodstream Under Shear Flow

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2016-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1161/ATVBAHA.115.307034PMID 26769048PMCID PMC4767639
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dimensional analysis and scaling relevant to flow models of thrombus formation: communication from the SSC of the ISTH

  2016cited by this paper
• Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor.

  2015cited by this paper
• Geometric design of microfluidic chambers: platelet adhesion versus accumulation

  2014cited by this paper
• Factor XI antisense oligonucleotide for prevention of venous thrombosis.

  2014cited by this paper
• A systems approach to hemostasis: 3. Thrombus consolidation regulates intrathrombus solute transport and local thrombin activity.

  2014cited by this paper
• A systems approach to hemostasis: 2. Computational analysis of molecular transport in the thrombus microenvironment.

  2014cited by this paper
• Microfluidics and coagulation biology.

  2013cited by this paper
• Evidence for factor IX‐independent roles for factor XIa in blood coagulation

  2013cited by this paper
• Inhibition of Factor XII-Mediated Activation of Factor XI Provides Protection Against Experimental Acute Ischemic Stroke in Mice

  2012cited by this paper
• Thrombography reveals thrombin generation potential continues to deteriorate following cardiopulmonary bypass surgery despite adequate hemostasis.

  2011cited by this paper
• Tortuosity triggers platelet activation and thrombus formation in microvessels.

  2011cited by this paper
• Coagulation procofactor activation by factor XIa

  2010cited by this paper
• Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk.

  2010cited by this paper
• Activated factor V is a cofactor for the activation of factor XI by thrombin in plasma

  2010cited by this paper
• A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo.

  2010cited by this paper
• Identification of Coagulation Factor XI as a Ligand for Platelet Apolipoprotein E Receptor 2 (ApoER2)

  2009cited by this paper
• Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI.

  2009cited by this paper
• Threshold Response of Initiation of Blood Coagulation by Tissue Factor in Patterned Microfluidic Capillaries Is Controlled by Shear Rate

  2008cited by this paper
• Factor XI contributes to thrombin generation in the absence of factor XII.

  2008cited by this paper
• Role of Factor XII in hemostasis and thrombosis: clinical implications

  2007cited by this paper
• The intrinsic pathway of coagulation: a target for treating thromboembolic disease?

  2007cited by this paper
• Variable bleeding manifestations characterize different types of surgery in patients with severe factor XI deficiency enabling parsimonious use of replacement therapy

  2006cited by this paper
• Platelet physiology and thrombosis.

  2004cited by this paper
• Thrombophilic families with inheritably associated high levels of coagulation factors VIII, IX and XI

  2003cited by this paper
• Platelet Aggregation and Activation under Complex Patterns of Shear Stress

  2002cited by this paper
• High levels of coagulation factor XI as a risk factor for venous thrombosis.

  2000cited by this paper
• Thrombin activates factor XI on activated platelets in the absence of factor XII.

  1999cited by this paper
• Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces.

  1991cited by this paper
• Factor XI activation in a revised model of blood coagulation

  1991cited by this paper

• The factor XIa antibody osocimab strongly inhibits clotting in extracorporeal circuits with human blood and in baboons

  2025cites this paper
• Inhibition of Factor XI: A New Era in the Treatment of Venous Thromboembolism in Cancer Patients?

  2023cites this paper
• Biology of Factor Xl.

  2023cites this paper
• Activation of coagulation FXI promotes endothelial inflammation and amplifies platelet activation in a nonhuman primate model of hyperlipidemia

  2023cites this paper
• Determination of the Potential Clinical Benefits of Small Molecule Factor XIa Inhibitors in Arterial Thrombosis

  2023cites this paper
• Commentary on “Pharmacological profile of asundexian, a novel, orally bioavailable inhibitor of factor XIa”: Small molecule factor XIa inhibitor asundexian allows for safer anticoagulation

  2022cites this paper
• Revised model of the tissue factor pathway of thrombin generation: Role of the feedback activation of FXI

  2022cites this paper
• Flow-Based Coagulation and Fibrinolysis Assays

  2020cites this paper
• Microfluidic endothelium-on-a-chip development, from in vivo to in vitro experimental models

  2020cites this paper
• CD36‐fibrin interaction propagates FXI‐dependent thrombin generation of human platelets

  2020cites this paper
• Platelet-primed interactions of coagulation and anticoagulation pathways in flow-dependent thrombus formation

  2020cites this paper
• Intrinsic Coagulation Pathway, History of Headache, and Risk of Ischemic Stroke.

  2019cites this paper
• Protease-activated receptor 4 activity promotes platelet granule release and platelet-leukocyte interactions

  2019cites this paper
• The contact pathway and sepsis

  2019cites this paper
• Potentiation of thrombus instability: a contributory mechanism to the effectiveness of antithrombotic medications

  2018cites this paper
• Design and Utility of a Point-of-Care Microfluidic Platform to Assess Hematocrit and Blood Coagulation

  2018cites this paper
• Effect of Pneumatic Tubing System Transport on Platelet Apheresis Units

  2018cites this paper
• Reporting Sex and Sex Differences in Preclinical Studies.

  2018cites this paper
• An update on factor XI structure and function.

  2018cites this paper
• Factor XII Activation Promotes Platelet Consumption in the Presence of Bacterial-Type Long-Chain Polyphosphate In Vitro and In Vivo

  2018influential citation
• Platelet biology and functions: new concepts and clinical perspectives

  2018cites this paper
• Clinical Case: A 28-Year-Old G1P0 with Mild Ventriculomegaly

  2017cites this paper
• Fibrinogen and Fibrin in Hemostasis and Thrombosis.

  2017cites this paper
• Use of microfluidics to assess the platelet-based control of coagulation

  2017cites this paper
• Tissue‐engineered 3D microvessel and capillary network models for the study of vascular phenomena

  2017cites this paper
• Utility of microfluidic devices to study the platelet–endothelium interface

  2017cites this paper
• Biorheology of Platelet Activation in the Bloodstream Distal to Thrombus Formation

  2016cites this paper
• Dynamics of Blood Flow and Thrombus Formation in a Multi-Bypass Microfluidic Ladder Network

  2016cites this paper
• Dynamics of Thrombin Generation and Flux from Clots during Whole Human Blood Flow over Collagen/Tissue Factor Surfaces*

  2016cites this paper
• Prothrombotic skeletal muscle myosin directly enhances prothrombin activation by binding factors Xa and Va.

  2016cites this paper